CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) vs Soligenix Inc. (SNGX)

CollPlant Biotechnologies Ltd. Sponsored ADR and Soligenix Inc. are both Biotechnology companies. CollPlant Biotechnologies Ltd. Sponsored ADR and Soligenix Inc. are of similar size ($7.5M and $7.3M). Soligenix Inc. grew revenue faster over the last twelve months: −50.4% against −86.8%. Soligenix Inc. has the higher net margin (0.00% vs −3,934.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Soligenix Inc. leads on 11 and CollPlant Biotechnologies Ltd. Sponsored ADR on 5.

Valuation

Metric CLGN SNGX Biotechnology median
P/E n/m n/m 10.26
P/S 18.24 10.97 9.18
P/B 1.97 0.82 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.18 0.65
EV/Sales 26.12 (4.05) 8.98
Earnings yield (235.64%) (372.59%) (34.89%)
Free cash flow yield (193.83%) (179.73%) (24.52%)

Profitability

Metric CLGN SNGX Biotechnology median
Gross margin (321.70%) 0.00% 65.16%
Operating margin (3,900.94%) 0.00% 0.00%
Net margin (3,934.91%) 0.00% 0.00%
Free cash flow margin (3,522.64%) 0.00% 0.00%
Return on equity (161.98%) (241.65%) (50.12%)
Return on assets (101.59%) (125.95%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CLGN SNGX Biotechnology median
Revenue growth (TTM) (86.76%) (50.37%) 6.26%
EPS growth (last fiscal year) 35.17% 57.03% 29.88%
Revenue growth, 5-year CAGR (17.32%) (51.88%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLGN SNGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.57 2.77 4.89
Net debt to EBITDA 0.56 0.67 1.01

Dividend

Metric CLGN SNGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CLGN SNGX Biotechnology median
Market cap 7.45m 7.26m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack